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1292 The Journal of Thoracic and CardObjective: With recent advances in diagnostic imaging, the value of autopsy has
been called into question. The aim of our study was to assess the current impact of
autopsy for early postoperative quality management in cardiac surgery.
Methods: Between 2000 and 2003, a total of 14,313 patients underwent cardiac
surgery at our center. Of these, 898 patients (6.3%) died, and autopsy was performed
in 468 cases (52.1%). Data from clinical and postmortem examination were pro-
spectively analyzed regarding causes of death, postoperative complications, con-
comitant diseases, and surgery-associated pathologic findings.
Results: Mean age was 68.7 years. Mean survival was 13.9 postoperative days. On
autopsy, causes of death were cardiac in 49.8% of cases (n  233), respiratory in
8.3% (n  39), cerebral in 6.4% (n  30), abdominal in 4.7% (n  22), multiorgan
failure or sepsis in 14.9% (n  70), pulmonary embolism in 6.6% (n  31),
procedure associated in 8.3% (n  39), and others in 0.9% (n  4). Discrepancies
between clinical and postmortem determinations of cause of death were found in
108 cases (23.1%). These were acute myocardial infarction (n  38), low cardiac
output (n 9), respiratory (n 8), cerebral (n 5), abdominal (n 7), multiorgan
failure or sepsis (n  12), pulmonary embolism (n  18), and procedure associated
(11). Clinically unrecognized postoperative complications were found in 364 cases
(77.8%). Unknown concomitant diseases were found in 464 cases (99.1%), with
potential therapeutic relevance in 90 cases (19.2%). In 85 cases (18.2%), autopsy
examination revealed 96 premortem unrecognized surgery-associated pathologic
findings.
Conclusion: A high overall discrepancy rate between premortem and autopsy
diagnoses was recognized. Autopsy revealed clinically relevant information in a
significant number of cases. Therefore autopsy remains essential for quality assess-
ment in perioperative treatment.
To reduce unfavorable patient outcomes and to learn from previous misjudg-ments, detailed information should be available regarding patients who die inthe early postoperative course after cardiac surgery to reflect individual
surgical indication and analyze surgical and postoperative treatment. This includes
an accurate determination of cause of death and critical recognition of perioperative
complications. Both can be achieved by autopsy examination and subsequent
postmortem evaluation.1-7 In the past, autopsy has been the widely accepted crite-
rion standard for the evaluation of causes of in-hospital death. This is in contrast to
a dramatic fall in autopsy rate in most countries in recent years. The aim of this
study was to prospectively assess the current value of autopsy examination as an
instrument for quality management in cardiac surgery. We compared clinical and
autopsy findings concerning the confirmation of causes of death and the recognition
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of clinically unknown concomitant diseases, premortem un-
expected technical failures, and surgery-associated patho-
logic findings were evaluated.
Material and Methods
Patients and Procedures
Between January 2000 and December 2003, there were 898 post-
operative deaths, resulting in an overall in-hospital mortality of
6.3% and a corresponding 30-day mortality of 5.4%. Informed
consent was obtained for 468 patients (52.1%), forming the study
population. Autopsy was performed for clinicopathologic reasons
in all cases.
Study Protocol
Clinical data for all in-hospital deaths after cardiac surgery were
prospectively recorded. Clinical causes of death were determined
by the intensive care unit (ICU) physicians, taking into consider-
ation available clinical data, the postoperative ICU course, and
specific surgical aspects. A detailed hospital report, including the
clinical cause of death, perioperative complications, and all known
concomitant diseases, was appended to the certificate of death and
sent to the pathologist.
Autopsy examination was performed on average 2.9 1.5 days
after death (range 1-8 days) through standard incisions. Each
patient underwent standard sampling of the coronary arteries and
the myocardium, as well as any other relevant organ. At minimum
four sections of ventricular myocardium were taken, and acute
myocardial infarction (AMI) was diagnosed by hematoxylin and
eosin staining. A clinically based case summary was presented by
the surgeon at the regular mortality and morbidity conference,
followed by a detailed presentation of autopsy findings by the
pathologist, including autopsy-determined cause of death. There-
fore all clinical data were included to find an autopsy-based cause
of death in accordance with the clinicians. Additional notes from
the postmortem reports were analyzed and compared with clinical
data concerning postoperative complications, as well as concom-
itant diseases, noting agreements or contradictions. Premortem
known and unexpected pathologies of the surgical situs were also
recognized. Multiple preoperative and postoperative variables
were recorded (Table 1).
Definitions
Cardiac cause of death was defined clinically as attributable to
acute heart failure (AHF, low cardiac output syndrome), with or
without signs of acute AMI or sudden cardiac death (SCD).
AHF without AMI was defined as failure of at least one ven-
tricle resulting in pulmonary edema, acidosis, hypotension, and
consecutive organ failure, including valve dysfunction and ar-
rhythmias. AHF was confirmed by autopsy in the presence of
acute dilated ventricles, pulmonary edema, and secondary organ
damage but no evidence for another primary cause of death.
AHF with AMI was assumed as the cause of death in the
presence of AMI large enough to account for low cardiac output
syndrome. SCD was defined as immediate, unexpected death
within 1 hour as a result of cardiac problems or in patients
The Journal of Thoracicfound dead on the regular ward after an uneventful postopera-
tive course.
Nonseptic and septic multiorgan failure (MOF) were defined
in accordance to the definition of the American College of
Chest Physicians and Society of Critical Care Medicine Con-
sensus Conference.8 MOF was assessed in patients with pri-
mary organ failure of at least two organ systems and corre-
sponding morphologic findings on the condition that no single
organ damage could be identified as predominant cause of
death. MOF was not assessed in patients with secondary organ
damage caused by ischemia or hypoxia as a result of cardiac or
pulmonary failure. Fatal pulmonary embolism (PE) was pre-
sumed to be cause of death in patients with obliteration of at
least two lobular pulmonary arteries with typical clinical find-
ings and in the absence of evidence for another cause of death.
Statistics
Data were 100% complete for premortem and postmortem records.
Results are expressed as mean  SEM. Data were compared with
TABLE 1. Patient characteristics, surgical procedures, and
major postoperative treatment
Autopsy patients
(n  468)
Nonautopsy
patients
(n  430)
Age (y) 68.7  11.3 70.5  9.5
Male (%) 65.2% 62.3%
Coronary artery disease (%) 63.9% 65%
History of AMI (%) 33.1% 33.6%
Diabetes (%) 40.6% 39.3%
Arterial hypertension (%) 70.5% 73.2%
Body mass index (kg/m2) 30.1  5.0 29.6  6.3
Additive EuroSCORE 11.4  4.3 11.7  3.9
Log EuroSCORE 32.4  24.2 31.9  22.8
Ejection fraction (%) 38.5%  16.3% 40.9%  18.4%
Emergency indication (%) 32.9% 33.5%
Urgent indication (%) 22% 22.8%
Standalone CABG
procedure (%)
49.1% 51.4%
Aortic valve surgery (%) 10.2% 10.0%
Mitral valve surgery (%) 7.2% 7.0%
CABG with valve surgery (%) 9.2% 8.8%
Reoperation (%) 22.2% 19.3%
Preoperative low cardiac
output (%)
27.6% 25.4%
Preoperative IABP (%) 11.3 14.9
Perioperative IABP (%) 24.8 22.8
Postoperative hemodialysis (%) 54.9 57.2
Perioperative ECLS (%) 8.8 9.8
Postoperative laparotomy (%) 12.4 12.1
Rethoracotomy (%) 43.6 50.1
Postoperative survival (d) 13.9 (0-122) 15.3 (0-141)
IABP, Intra-aortic balloon pump; ECLS, extracorporeal life support. P was
not significant for all differences between groups. Values are given as
mean  SD or mean and range.the 2 test or 2-tailed Student t test as appropriate. SPSS 11.0
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ration, Redmond, Wash) were used for statistical calculation. Va-
lidity of each clinical cause of death was expressed as positive
predictive value. Clinical assessment of each cause of death was
expressed as sensitivity.
Results
Overall in-hospital mortalities were 3.8% for elective pro-
cedures and 19.4% for emergency indications. Comparison
of the patients who did and did not undergo autopsy re-
vealed no significant differences (Table 1).
Causes of Death
Clinical and autopsy causes of death are shown in Table 2.
TABLE 2. Confirmation and contradiction of clinical cause
Cause of death
Clinical Autop
No. % No.
Cardiac 220 47.0 233
AHF with AMI 112 23.9 163
AHF without AMI 76 16.3 62
SCD 32 6.8 8
Respiratory 57 12.2 39
ARDS 8 1.7 17
Pneumonia 44 9.4 17
Lung bleeding 5 1.1 5
Cerebral 29 6.2 30
Stroke 17 3.6 18
Bleeding 5 1.1 5
Primary edema 6 1.3 6
Cerebral embolism 1 0.2 1
Abdominal 23 4.9 22
Intestinal ischemia 13 2.8 11
Intestinal perforation 6 1.3 6
Pancreatitis 1 0.2 4
Liver failure 2 0.4 1
Others 1 0.2 0
MOF 88 18.8 70
Septic 51 10.9 42
Nonseptic 37 7.9 28
PE 16 3.4 31
Procedure associated 29 6.2 39
Bleeding 7 1.5 12
Aortic rupture 4 0.9 5
Left ventricular rupture 6 1.3 7
Tamponade 1 0.2 4
Aortic dissection 6 1.3 6
Mediastinitis 5 1.1 5
Others 6 1.3 4
Total organ related 468 100.0 468
Total diagnosis related 468 100.0 468
ARDS, Adult respiratory distress syndrome. Confirmation represents posi
clinically assumed causes of death. Sensitivity represents correctly determ
examination.On the basis of an organ-related evaluation, we found a
1294 The Journal of Thoracic and Cardiovascular Surgery ● Junconfirmation by autopsy of the clinically assumed causes of
death in 76.9% of cases. Confirmation was comparatively
high for cardiac (84.5%), cerebral (86.2%), and procedure-
associated causes of death (96.6%) and for fatal PE (81.3%).
Confirmation was worse for clinically determined death
related to respiratory (54.4%) or abdominal (65.2%) causes
and for MOF (65.9%).
Regarding diagnosis-related causes of death we found
some significant discrepancies. Prediction of cardiac death
from AMI was better than prediction of AHF without AMI
or SCD. Clinically presumed respiratory causes of death
were not confirmed by autopsy for a significant number of
patients, 37.5% for adult respiratory distress syndrome and
death by autopsy findings
Confirmation Contradiction Sensitivity
(%)No. % No. %
8 186 84.5 34 15.5 79.8
8 95 84.8 17 15.2 58.3
3 43 56.6 33 43.4 69.4
7 8 25.0 24 75.0 100.0
3 31 54.4 26 45.6 79.5
6 5 62.5 3 37.5 29.4
6 14 31.8 30 68.2 82.3
1 2 40.0 3 60.0 40.0
4 25 86.2 4 13.8 83.3
8 13 76.5 4 23.5 72.2
1 5 100.0 0 0 100.0
3 6 100.0 0 0 100.0
2 1 100.0 0 0 100.0
7 15 65.2 8 34.8 68.2
3 9 69.2 4 30.8 81.2
3 4 66.6 2 33.3 66.6
9 1 100.0 0 0 25.0
2 1 50.0 1 50.0 100.0
0 0 1 100.0
9 58 65.9 30 34.1 82.8
0 37 72.5 14 27.5 88.1
0 21 56.7 16 43.2 75.0
6 13 81.3 3 18.7 41.9
3 28 96.6 1 3.4 71.8
6 7 100.0 0 0 58.3
1 4 100.0 0 0 80.0
5 6 100.0 0 0 85.7
9 1 100.0 0 0 25.0
3 6 100.0 0 0 100.0
1 4 80.0 1 20.0 80.0
9 4 66.7 2 33.3
0 360 76.9 108 23.1
0 310 66.2 158 33.8
redictive value, autopsy-confirmed clinical cause of death related to all
clinical cause of death related to causes of death recognized by autopsys of
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deaths were appropriate. For diagnosis-related causes of
death, overall confirmation between clinical and autopsy
causes of death was only 66.2% (Table 2).
Cardiac causes of death were identified by autopsy in
49.8% of our cases but had been clinically presumed as
cardiac in 186 cases only. This resulted in a clinical sensi-
tivity of cardiac cause of death of 79.8%. Regarding cardiac
death from AMI, the sensitivity was reduced to 58.3%.
Clinical sensitivity was also low for adult respiratory dis-
tress syndrome (29.4%), lung bleeding (40.0%), pancreatitis
(25.0%), PE (41.9%), and pericardial tamponade (25.0%). It
was high for cerebral and other procedure-associated causes
of death and for SCD.
With respect to organ-related causes of death, we
found unexpected deaths in 108 cases (23.1%). With
diagnosis-related analysis, discrepancies between clinical
and autopsy causes of death became more evident, lead-
ing to 158 clinically unexpected causes of death (33.8%).
The main reason for this finding was that AMI could be
identified by clinical assessment in only 58.3% of the
patients (95/163; Table 3). Cause of death was assessed
clinically in these patients as cardiac (low cardiac output
without AMI or SCD; Table 3) or extracardiac, usually
pneumonia and MOF. Other significant discrepancies
were found in the respiratory system. Among patients
with clinically presumed pneumonia, this cause of death
was confirmed by autopsy for only 31.8%. Contradictory
autopsy causes of death in these patients were frequently
AMI and adult respiratory distress syndrome.
Fatal PE was identified as cause of death in 31 cases
TABLE 3. Clinical and autopsy causes of death
Clinical
AHF
with
AMI
AHF,
no
AMI SCD ARDS Pneumonia
Lung
bleeding
AHF with AMI 95 9
AHF, no AMI 16 43 2 2
SCD 14 1 8 1
ARDS 5 1
Pneumonia 11 3 9 14
Lung bleeding 1 2
Cerebral 1 2
Abdominal 4 1
Septic MOF 7 1 3
Nonseptic MOF 12 2
PE
Procedural
Others 2
Total 163 62 8 17 17 5
AHF, Acute heart failure; ARDS, adult respiratory distress syndrome.(6.6%). For 13 of these patients (41.9%), the diagnosis
The Journal of Thoracichad been clinically assumed; however, in 18 cases, PE
could not be identified before death. Clinically assumed
causes of death in these patients were predominantly
AMI (n  4), SCD (n  4), and pneumonia (n  4). In
another 3 cases, PE was clinically diagnosed but could
not be confirmed by autopsy. In 2 of these cases, tech-
nical failures were responsible for death (pericardial tam-
ponade, coronary artery bypass grafting [CABG]
bleeding).
A reason for SCD was found by autopsy in 24 of 32 cases
(Table 3). Four procedure-associated reasons were CABG
bleeding, left ventricular rupture, pericardial tamponade,
and aortic rupture. In the remaining 8 cases, no decisive
findings for death were found. These patients had unwit-
nessed SCD, and malignant arrhythmia had to be assumed.
Six of these patients had undergone aortic valve surgery.
Perioperative Complications
A total of 783 perioperative complications were found in
364 of 468 patients at autopsy (77.8%, mean 2.2 complica-
tions/patient). Most (n 606, 77.4%) were unknown before
death (Figure 1). Pathologic findings included arterial em-
bolism in 34 patients (52.9% clinically undetected), deep
venous thrombosis (DVT) of the upper extremity in 179
(96.6%), DVT of the lower extremity in 63 (93.7%), minor
PE in 96 (91.7%), pneumonia in 106 (44.3%), acute splenic
infarction in 87 (83.9%), acute renal infarction in 57
(93.9%), minor stroke in 52 (42.3%), minor cerebral bleed-
ing in 29 (79.3%), intestinal ischemia in 37 (62.2%), intes-
tinal perforation in 18 (72.2%), and acute pancreatitis in 25
(56.0%). We found no significant relation between these
Autopsy
ebral Abdominal
Septic
MOF
Nonseptic
MOF PE Procedural Others Total
1 1 1 4 1 112
2 3 1 2 2 3 76
4 4 32
1 1 8
1 2 4 44
1 1 5
5 1 29
15 3 23
2 37 1 51
1 21 1 37
1 13 2 16
1 28 29
4 6
0 22 42 28 31 39 4 468Cer
2
3pathologic findings and the surgical procedure performed,
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operation.
Concomitant Diseases
A total of 928 of the following diseases could be morpho-
logically identified in 464 patients (99.1%) by autopsy. Of
these, 535 were unknown before death, representing 57.6%.
In detail, myocardial hypertrophy was found in 187 patients
(36.4% clinically undetected), occlusive arterial disease in
77 (48.1% clinically undetected), former DVT in 30 (33.3%
clinically undetected), pulmonary emphysema in 77
(41.6%), former PE in 27 (18.5%), former stroke in 44
(31.8%), renal cyst in 83 (88.0%), liver degeneration in 53
(90.6%), liver cirrhosis in 58 (48.3%), bile stone disease in
51 (78.4%), chronic pancreatitis in 14 (85.7%), colon di-
verticulosis in 60 (83.3%), benign tumors in 102 (78.3%),
and malignant tumors in 65 (44.6%). Malignant tumors
were lymphoma in 8 cases (n  3), lung carcinoma in 7 (n
 3), renal carcinoma in 5 (n  4), prostatic carcinoma in
15 (n  6), colorectal carcinoma in 9 (n  3), breast
carcinoma in 4 (n  0), and others in 17 (n  10).
Unexpected occlusive artery disease (n  37), liver
cirrhosis (n  28), and malignant tumors (n  29) were
considered to be of relevance for surgical indication and
therapy. These were found in 90 patients, representing
19.2% of the study population. Unexpected occlusive arte-
rial disease was found in 19 of 130 (14.6%) of emergency
patients versus 18 of 338 (5.3%) of nonemergency patients
(P  .001). Unknown liver cirrhosis was recognized in
13.8% of patients with emergency indications versus 3.0%
with nonemergency indications (P  .001). Incidences of
premortem unrecognized malignant tumors were 6.9%
among emergency patients versus 5.9% among nonemer-
gency patients (P  .49).
Technical Failures and Surgical Pathologic Findings
In total, 96 premortem unknown surgery-associated patho-
logic findings were revealed by autopsy examination in 85
patients (18.2%), including 45 patients (9.6%) with signif-
icant CABG dysfunction. In addition, significant numbers
of clinically undetected intracardiac (1.2%) and prosthetic
valve thrombi (3.6%) were found. Other unexpected find-
ings were bleeding (1.1%), tamponade (0.6%), prosthetic
valve endocarditis (0.4%), ostial right coronary artery ste-
nosis after aortic valve replacement (0.9%), unknown native
coronary artery disease (1.5%), left ventricular dissection
(0.2%), aortic rupture (0.2%), mediastinitis (0.2%), and
others (0.9%).
Discussion
In recent years, quality management in medicine has fo-
cused on the development of new instruments to improve
medical services and allow internal and external quality
1296 The Journal of Thoracic and Cardiovascular Surgery ● Juncontrol. Particularly in operative disciplines, these mecha-
nisms are mandatory to guarantee modern and accurate
surgical treatment. In parallel, scoring systems and risk
stratifications have been developed, allowing a more mean-
ingful comparison of surgical results. All such instruments
urgently need extensive information about patient charac-
teristics and perioperative outcome. Surprisingly, autopsy
examination, although a proven instrument for quality as-
sessment, has decreased dramatically in the past
decades.4,5,9,10 One reason for this conflicting development
could be the misconception that current diagnostic tools are
highly accurate, making autopsies unnecessary. However,
several studies disprove this factor by demonstrating con-
sistent discrepancies between clinical and autopsy findings
during different diagnostic eras.5,9-11
In the few published reports of postmortem findings after
cardiac or thoracic surgery, the autopsy rate ranged from
24% to 88%, significantly higher than autopsy rates re-
ported for the average hospital population.12-18 Most of our
patients dying after cardiac surgery had urgent or emer-
gency surgical indications and were at high risk for unfa-
vorable outcome, as expressed by increased preoperative
risk score. Regarding patient age and postoperative survival,
our findings are similar to previously published series in
cardiac surgery (Table 4).
Regarding causes of death from other series, some dis-
crepancies are evident. Obviously, the rate of cardiac-
related deaths in our patients was similar to findings by Lee
and Gallagher13 but was higher than in the series reported
by Zehr and associates14 and lower than in the series of
Deiwick and associates12 and Goodwin and coworkers.15
Reasons might be the high proportion of death of unknown
cause reported by Zehr and associates,14 subtle differences
in final autopsy assessment, differences in patient charac-
teristics, and study population size. These could also be
reasons for differences in proportion of deaths from abdom-
inal and respiratory causes or surgery-associated causes of
death.
In accordance with Barendregt and colleagues,3 we
found a comparatively high confirmation of more than 80%
for cardiac, cerebral, and procedure-associated causes of
death.3 In addition to typical clinical symptoms, potential
reasons for the good prediction of these causes of death
might be such highly sensitive and specific diagnostic tools
as computed tomographic scan and hemodynamic monitor-
ing, allowing early and reliable evaluation. Worse sensitiv-
ities were observed for PE and for respiratory and abdom-
inal causes. This might be explained by more unspecific and
atypical clinical symptoms, especially in intubated and se-
dated patients. In other words, early recognition of abdom-
inal and respiratory complications might be more difficult
for cardiac surgeons.
e 2005
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ancy rate in our series between clinical and autopsy causes
of death was 23.1%; it increased to 33.8% when using a
diagnosis-related analysis. Unexpected causes of death were
slightly higher than reported in other series (Table 4).12-16
However, the extent of confirmation between clinically as-
sumed and autopsy causes of death was strongly dependent
on the underlying causes of death. It varied between 25%
for SCD—a usually ambiguous clinical situation—and
100% for most cerebral and procedure-associated causes of
death.
A major reason for discrepancies between diagnosis-
related clinical and autopsy causes of death was that cardiac
failure resulting from AMI could not be clinically identified
as a cause of death in a significant number of cases. Thus it
can be presumed that surrounding clinical circumstances
with further organ dysfunctions make it more difficult for
the ICU physician to focus on this cardiovascular event.
AMI was associated with bypass graft dysfunction in 18
patients only. On the other hand, 108 patients had AMI
despite good graft function, and 37 had AMI in the absence
Figure 1. Incidences of perioperative complications as
represent complications identified by autopsy examina
tions. Note high rate of clinically unknown thromboemb
extremity.of significant coronary artery disease. This would suggest
The Journal of Thoracicthat most AMIs stemmed from intraoperative ischemia-
reperfusion damage.
Regarding PE, literature data support an incidence of
0.4% to 9.5% after cardiac surgery, and 0.3% to 1.7% of
these events are fatal.19,20 Because of this rather low inci-
dence, PE is considered to be an uncommon cause of death
for the average patient after cardiac surgery. In autopsy
studies of cardiothoracic patients, however, fatal PE is com-
mon and has been reported as a cause of death for 4.1% to
5.5%.13,14,17 In our study, this cause of death was unrecog-
nized clinically, representing 11.4% of all unexpected
deaths.
Little is known about patients with SCD after an un-
eventful postoperative course.16 By autopsy, it was possible
to clarify the cause of death for 75% of the 32 patients with
SCD. This included acute myocardial infarction in 14 cases.
However, in 8 cases no morphologic reason could be iden-
tified, and arrhythmia was assumed to be the final cause of
death.
Anticoagulation was partial thromboplastin time–
adjusted intravenous heparinization (1.5-2 fold) for all pa-
entages of all patients studied by autopsy. Striped bars
white bars represent premortem unknown complica-
findings. Art., Arterial; u.e., upper extremity; l.e., lowerperc
tion;
olictients in the ICU and combined antiplatelet and subcutane-
and Cardiovascular Surgery ● Volume 129, Number 6 1297
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incidence of DVT is about 20% in the early postoperative
course after cardiac surgery, but it was clinically unnoticed
in most patients.21 Postoperative risk factors for DVT and
PE could be clearly identified as immobilization, obesity,
recent AMI, hyperlipidemia, coagulation disorders, and
central venous catheters.19 Taking this into consideration, it
is obvious that our patients were at highest risk for DVT
formation and PE. We also found arterial emboli in 7.3% of
the patients. Because of the high incidence of acute renal
and splenic infarction and the significant number of recog-
nized intracardiac and prosthetic valve thrombi by visual-
ization, we have to conclude that prophylaxis against throm-
boembolic events remain one of the most challenging fields
in the postoperative course after cardiac surgery.
Abdominal complications were identified by autopsy in
80 patients. About two thirds were not clinically recognized.
Thus the gastrointestinal tract was of considerable relevance
in our study. In particular, for abdominal disorders an early
gastroenterologic assessment and consultation of abdominal
surgeons might help to identify abdominal disorders earlier
and reduce abdominal-associated morbidity and mortality.
We found coronary bypass dysfunction to be the main
surgical failure, in 15% of all patients. In two thirds of these
patients (9.6%), it was clinically unrecognized. Only 1
autopsy study has focused on that issue; it derived from the
venous bypass graft era and reported bypass dysfunction in
29% after a mean of 153 postoperative days.22 However,
bleeding, tamponade, and prosthetic valve endocarditis, as
well as left ventricle dissection, pericardial tamponade, and
TABLE 4. Comparison of previously published series of po
Current study
Lee and Gall
1997
No. of patients 468 108
Country Germany UK
Autopsy rate (%) 52.1 87.8
Mean patient age (y) 68.7 Unspeci
Postoperative survival (d) 13.9 50% 1
Autopsy cause of death (%)
Cardiac 49.8 52.0
Respiratory 8.3 2.4
Cerebral 6.4 5.7
Abdominal 4.7 3.3
MOF 14.9 3.2
PE 6.6 4.9
Procedure associated 8.3 14.6
Others 0.9 0
Not clarified 0 13.9
Clinically unexpected
organ-related death (%)
23.1 14.8aortic rupture, were seen in individual patients and were
1298 The Journal of Thoracic and Cardiovascular Surgery ● Junjointly responsible for surgery-associated mortality in 8.3%
of the cases.
Increasing patient age is associated with an increasing
number of severe comorbidities and adverse perioperative
outcome.23,24 Liver cirrhosis was found in 12.4% of our
patients, with 50% unknown before death. These severe
comorbidities pose additional patient risk, particularly in
cardiac surgery and associated transesophageal echocardi-
ography. Liver cirrhosis was unrecognized more frequently
in patients with emergency indications, reflecting a special
risk to patients without thorough examination. Taking this
into consideration, a liberal indication for abdominal ultra-
sonography, especially for unscheduled patients, has be-
come part of our protocol.
Unknown malignant tumors were recognized by autopsy
in 6.2% of the patients. Presumably only in a minority of
cases a more detailed tumor screening would reveal the
malignancy and would lead to a reassessment of the indi-
vidual surgical indication. Nevertheless, this finding under-
lines the high risk for severe comorbidities in our elderly
patient population.
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Discussion
Dr Edward Verrier (Seattle, Wash). This is a remarkable study,
as it must be because we are looking at autopsies, of 16,464
operations in 14,313 patients undergoing elective, urgent, and
emergency cardiac procedures during a relatively short concurrent
4-year period. In all, 898 patients, died for an overall mortality of
6.3%, which was constant through the 4-year period. I believe the
results represent an outstanding clinical experience from a single
institution. The autopsy rate was 52%, which is also remarkable in
an era when overall postmortem examination rates have decreased,
the most obvious reason being the fear of medicolegal recrimina-
The Journal of Thoracictions. The article contains a huge amount of information, much of
which is relevant and useful because of the large cohort size and
the careful analysis. I encourage all cardiac surgeons to read the
published article.
The overall correlation between the clinical assessment and the
autopsy confirmation of death was 76%. One of the most striking
observations was the high confirmation rates between clinical
assessment and autopsy for cardiac causes (85%), cerebral causes
(86%), procedure-related causes (96%), and fatal PE (81%). In
contrast, the confirmation rates for respiratory distress and pneu-
monia (54%), abdominal causes (65%), and MOF (66%) were
much lower.
My first question, Dr Rastan, is what have you learned from
these observations, and how has it affected your clinical practice
prospectively? Are there better yet cost-effective ways to assess
the lungs or abdomen either preoperatively or perioperatively that
would lead either to more aggressive diagnostic definition or to
alternative therapeutic strategies? Are there patient cohorts with
we should be more aggressive in using chest or abdominal com-
puted tomography, magnetic resonance imaging, noninvasive vas-
cular testing, or assay of systemic markers of inflammation? We
already have literature stating that extensive screening tests are
often not cost-effective without symptoms. We also know that
broad-spectrum antibiotic use or aggressive anticoagulation regi-
mens are double-edged swords in terms of risk-benefit ratio. What
are your thoughts?
Dr Rastan. Thank you, Dr Verrier, for your comments. Think-
ing about consequences, we have to find individual therapeutic
strategies for elderly patients, bearing in mind that a third of our
study population (n  284) were 75 years or older. This includes
asking patients at risk to come to our surgical outpatient depart-
ment for evaluation of their cardiac symptoms, comorbidities, and
cerebral status and discussing their individual surgical risk. Ther-
apeutic options could include off-pump CABG procedures and
hybrid minimally invasive direct CABG procedures or asking the
cardiologists for percutaneous coronary intervention, being aware
that we would achieve only incomplete revascularization in indi-
vidual patients. However, the more we decline to operate on
patients in critical condition, the more we can reduce mortality.
Therefore mortality could be significantly reduced by refusing to
operate on patients with cardiogenic shock, for example, which we
accept liberally at the moment.
Another point is the timing of operation, bearing in mind that
overall mortality increased to 9.3% for urgent indications and
19.4% for emergency indications. In selected patients with acute
coronary symptoms, a delayed operation could be of benefit by
allowing myocardial recovery, accurate preoperative preparation,
and diagnostic evaluation.
A further consequence is to reflect about preoperative diagnos-
tics. I agree with you that nonspecific computed tomography and
magnetic resonance imagery will not be helpful in most cases. For
patients at risk, however, we have changed our protocol and use
ultrasonography, computed tomographic scan, and even nuclear
magnetic resonance more liberally, especially in emergency cases.
Additionally, we should encourage our cardiologists to carry
out a detailed preoperative medical evaluation of surgical candi-
dates, including abdominal ultrasonography. This could help to re-
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as malignancy, and to reduce unfavorable postoperative outcomes.
As I mentioned, our protocol includes an individual concept of
specific intravenous antibiotic therapy in every ICU patient. It is
our consensus that a more aggressive nonspecific treatment is not
appropriate.
Dr Verrier. There are certainly groups that have discrepancies.
For instance, you note a higher than expected discrepancy between
clinical and autopsy causes of death because congestive heart failure
was often not identified clinically as a problem leading to death.
What is the best way, for instance, to recognize subtleties of
postoperative heart failure? Longer hemodynamic monitoring,
more widespread use of myocardial enzymes as markers of injury?
Should we be keeping our marginal patients on inotropics longer?
Should we be more aggressive with the use of angiotensin-con-
verting enzyme inhibitors, selective -blockade, or natriuretic hor-
mone therapy, or more liberal with consultations? Have these types
of things come into the way you have changed your practice since
you have examined these data so carefully?
Dr Rastan. A total of 233 patients had autopsy-confirmed
cardiac causes of death. In 186 cases, cardiac causes of death were
clinically assumed. In the others, clinically assessed causes of
death were predominantly pneumonia and MOF. Most of these
patients had prolonged postoperative course of more than 2 weeks.
So we can conclude that lingering cardiac failure with and without
AMI still occurs weeks after the operation. Second is that in the
later postoperative course cardiac failure seems to be not as obvi-
ous as in the early postoperative period. Therefore one lesson is to
think of cardiac failure in these patients and to treat it as early as
possible by medical or mechanical means. Patients with remission
of early postoperative heart failure are especially at risk and should
be carefully monitored for a prolonged time with optimized heart
failure medication, including inotropics and intra-aortic balloon
pump when appropriate.
We are monitoring the cardiac enzymes carefully, and in every
case in which we suspect bypass dysfunction, we take the patient
back to the catheterization laboratory for angiography. Interest-
ingly, more than 90% of the patients with signs of AMI had
excellent bypass function. We found that AMI was more frequent
in patients with coronary artery disease, but it was not strongly
associated with bypass dysfunction in these patients. Not surpris-
ingly, it was evident that patients with combined procedures and
prolonged myocardial ischemia were at risk for AMI. So we have
to think about myocardial protection in the operating room, avoid-
ing long ischemia and doing beating-heart surgery in critical cases,
including patients with acute coronary syndrome.
Dr Verrier. The final striking observation is this very high
incidence of pathologic findings found perioperatively, 77% of the
patients, most of which weren’t known until post mortem, and
these include arterial emboli, phlebothrombosis, minor PE, pneu-
monia, splenic and renal infarction, minor cerebral events, intes-
tinal ischemia or perforation, and pancreatitis. In addition, a total
of 928 concomitant diagnoses were identified, of which only 464
had been identified postmortem, such as left ventricular hypertro-
phy, occlusive arterial disease, pulmonary emphysema, cirrhosis,
and malignancy. Of these conditions, you state that almost 20%
had surgical implications, 14% in the emergency group and 5% in
1300 The Journal of Thoracic and Cardiovascular Surgery ● Junthe elective group. If known, would the operations have not been
done, or would they have been better delayed, and if delayed, would
the knowledge have made a difference in the overall impact?
I guess the bottom line is this: how can we improve on the
numbers to actually benefit this sick group of patients, rather than
simply benefiting the statistics? I thank the Association for the
privilege of discussing this important article. Postmortem exami-
nation after cardiac surgery must remain a part of our quality
assurance programs.
Dr Rastan. The high rates of unknown concomitant diseases
were unexpected for us. In addition to unknown comorbidities of
minor operative impact, we also found severe comorbidities in 20%,
especially more than 6% of unknown malignancy. The knowledge of
severe comorbidities is a condition for successful surgery and more or
less influences the surgical indication and operative strategy. How-
ever, it is difficult to speculate about the individual dimension.
Regarding the postoperative complications, I just want to focus on
the surprisingly high incidence of thromboembolic events we found in
the venous system but also in the arterial system. Even though all
patients received adjusted intravenous anticoagulation with heparin,
we found an incidence of minor PE of 20%. Interestingly, most of
these events were clinically completely unrecognized. This makes us
aware that the anticoagulation regimen is one of the major challenges
for ICU patients, because our population is a subset of patients with
the highest risk for perioperative morbidity and mortality.
Dr Craig Smith (New York, NY). I think this is potentially very
important information, and you are to be congratulated on obtain-
ing a 52% autopsy rate, certainly far better than we achieve. It
would help me understand the clinical diagnoses you discuss if you
could express them, as we do for modalities like computed tomo-
graphic scan or magnetic resonance imaging, in terms of sensitiv-
ity and specificity. I’m particularly interested in one diagnosis that
we frequently consider in this setting but seldom confirm at au-
topsy, and that is PE. Can you tell me your sensitivity and spec-
ificity for the clinical diagnosis of PE?
Dr Rastan. Thank you, Dr Smith, for your question. In 16
patients of our cohort, fatal PE was clinically assumed as cause of
death. In 13 of these patients, PE was confirmed by autopsy,
leading to a confirmation or positive predictive value of this
clinical cause of death of 81.3%. On the other hand, by autopsy
fatal PE was found in 31 patients. Thus, the clinical sensitivity for
this cause of death was only 41.9%. So we have to keep this
diagnosis in mind.
Dr Mohr. Maybe I can have a final comment in terms of what
clinical impact it has, and the problem arising in the emergency
situation. We do have the situation that if we get the patients late
at night in the operating room, they have incomplete diagnoses. If
you look into patients with endocarditis, which occurs quite often,
they present with splenic emboli and so on. Now we insist on a
quick total body preoperative computed tomographic scan on these
patients, and if something is there, it is going to be solved in a
one-stage operation; we go for a one-stage splenectomy right
away, for example, as one of the situations. Also, the computed
tomographic scan helps to identify a mesenteric ischemia in some
patients preoperatively. So if we do see that, we have to consider
whether we should keep our hands off these patients.
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